Single sample expression-anchored mechanisms predict survival in head and neck cancer.

by Xinan Yang, Kelly Regan, Yong Huang, Qingbei Zhang, Jianrong Li, Tanguy Y Seiwert, Ezra E W Cohen, H Rosie Xing, Yves A Lussier
Published 2012-01-01

Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic...

by Yimin Xu, Yimin Xu, Gangcai Zhu, Gangcai Zhu, Gangcai Zhu, Christopher A. Maroun, Christopher A. Maroun, Irene X. Y. Wu, Donghai Huang, Donghai Huang, Donghai Huang, Tanguy Y. Seiwert, Tanguy Y. Seiwert, Yong Liu, Yong Liu, Yong Liu, Yong Liu, Rajarsi Mandal, Rajarsi Mandal, Xin Zhang, Xin Zhang, Xin Zhang, Xin Zhang
Published 2021-04-01

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

by Sara I. Pai, Sandrine Faivre, Lisa Licitra, Jean-Pascal Machiels, Jan B. Vermorken, Paolo Bruzzi, Viktor Gruenwald, Raul E. Giglio, C. René Leemans, Tanguy Y. Seiwert, Denis Soulieres
Published 2019-04-01

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.

by Tanguy Y Seiwert, XiaoZhe Wang, Jana Heitmann, Vivian Villegas-Bergazzi, Kam Sprott, Stephen Finn, Esther O'Regan, Allan D Farrow, Ralph R Weichselbaum, Mark W Lingen, Ezra E W Cohen, Kerstin Stenson, David T Weaver, Everett E Vokes
Published 2014-01-01